Skip to main content
. 2020 Apr;40(Suppl 1):S1–S86. doi: 10.14639/0392-100X-suppl.1-40-2020

Table 4.I.

National Comprehensive Cancer Network (NCCN) guidelines on staging of head and neck tumours, compared with AIOCC (Italian Association of Head and Neck Oncology) and AIOM (Italian Association of Medical Oncology).

Staging by imaging NCCN guidelines version 1.2019 AIOCC guidelines 2012 AIOM guidelines 2018
SCC oral cavity As clinically indicated:
  • Chest CT (with or without contrast) 1

  • CT with contrast and/or MRI with contrast of primary and neck

  • Panorex or dental CT without contrast

  • MRI of head and neck without and with contrast (first choice)

  • CT without and with contrast of head and neck

  • US of neck

  • PET/CT in locally advanced stages

  • Chest CT without and with contrast (if not done PET/CT)

  • Dental CT

If clinically indicated:
  • Liver US

  • Bone scintigraphy

Local staging with:
  • MRI of primary and neck with contrast (first choice) or CT of primary and neck with contrast

  • US of neck

  • Panorex (or dental CT)

Distant staging with:
  • PET/CT in selected cases (III-IV stages) or chest CT (in T1 and T2 it can be sufficient chest X-ray, except in strong smoker)

SCC oropharynx
  • CT with contrast and/or MRI with contrast of primary and neck

As clinically indicated:
  • FDG-PET/CT

  • Chest CT (with or without contrast) 1

  • Panorex

  • MRI (first choice) or CT (if MRI not feasible) of primary and neck

  • Chest CT

  • PET/CT for III-IV stages

Local staging with:
  • MRI (firs choice) or CT (if MRI not feasible)

Distant staging with:
  • Chest CT (III-IV stages; T1-2 at high risk)

  • PET/CT for stages III-IV

SCC hypopharynx
  • CT with contrast and/or MRI with contrast of primary and neck

As clinically indicated:
  • Chest CT (with or without contrast) 1

  • Consider FDG-PET-CT

  • CT or MRI + contrast of primary and neck

  • PET/CT for III-IV stages

  • Chest CT

Local staging with:
  • CT or MRI with contrast of facial massif and neck

Distant staging with:
  • Chest CT with contrast (PET/CT in III-IV stages)

Cancer of nasopharynx
  • MRI with contrast of skull base to clavicle +/- CT of skull base/neck with contrast to evaluate skull base erosion

  • Imaging for distant metastasis with FDG-PET/CT and/or chest CT with contrast

  • MRI (first choice) +/- CT of primary and neck

  • US of neck

  • Dental CT

  • CT total body + bone scintigraphy or PET/CT

Local staging with:
  • MRI (firs choice) +/- CT for skull base study

  • US of neck

Distant staging with:
  • PET/CT (in alternative CT total body + bone scindigraphy)

SCC glottic larynx
  • CT with contrast and thin angled cuts through larynx and/or MRI with contrast of primary and neck

As clinically indicated:
  • Chest CT (with or without contrast) 1

  • Consider FDG-PET/CT

  • CT/MRI of primary and neck

  • US of neck

  • Chest CT

  • PET/CT for III-IV stages

Local staging with:
  • CT with contrast (first choice)

  • MRI with dedicated superficial coils and sequences

  • US of neck

Distant staging with:
  • Chest CT with contrast or PET/CT in III-IV stages

SCC supraglottic larynx
  • Chest CT (with or without contrast) as clinically indicated 1

  • CT with contrast and thin angled cuts through larynx and/or MRI with contrast of primary and neck

  • Consider FDG-PET/CT

Ethmoid sinus tumors
  • CT with contrast or MRI with contrast of skull base

As clinically indicated:
  • Chest CT (with or without contrast) 1

  • Consider FDG-PET/CT

  • MRI and/or CT (skull base to clavicle) with contrast (axial, sagittal and coronal projections)

  • Chest and abdomen CT + bone scintigraphy or PET/CT for more aggressive tumors

(Same guidelines for all sinonasal tumors)
  • MRI and/or CT (skull base to clavicle) with contrast (particular attention on parapharyngeal chain)

  • Chest X-ray (in less aggressive histotypes)

  • Chest and abdomen CT + bone scintigraphy or whole body PET/CT for more aggressive tumors

(Same guidelines for all sinonasal tumors)
Maxillary sinus tumors
  • Complete head and neck CT with contrast and/or MRI with contrast

As clinically indicated:
  • Chest CT (with or without contrast) 1

  • Consider FDG-PET/CT

Salivary gland tumors
  • FNA biopsy

As clinically indicated:
  • CT/MRI with contrast of skull base to clavicle

  • Chest CT (with or without contrast) 1

  • Chest X-ray

  • Neck US + FNA

  • CT/MRI with contrast for the study of deep parotid lobe or in III-IV stages

  • US of neck + FNAB

  • CT/MRI with contrast of primary and neck

Mucosal melanoma
  • CT with contrast and/or MRI with contrast to determine anatomic extent of disease, particularly for sinus disease

As clinically indicated:
  • Chest CT (with or without contrast) 1

  • Consider FDG-PET/CT or chest/abdominal/pelvic CT with contrast, and brain MRI (with and without contrast) to rule out metastatic disease

1: Chest CT is recommended for advanced nodal disease to screen for distant metastasis and for selecting patients who smoke, to screen for lung cancer.